Management Advice for Families with Polyposis Syndrome
Families with a history of polyposis syndrome should undergo genetic testing to identify the specific mutation, followed by targeted surveillance only for mutation carriers, with surveillance protocols tailored to the specific syndrome type. 1
Genetic Testing Approach
- All patients diagnosed with polyposis syndrome should be referred to a Regional Genetics Centre for formal genetic counseling and mutation analysis of the respective gene 1
- Family members of affected individuals should undergo genetic testing for the specific mutation identified in the family 1
- If the family mutation is known, mutation-specific germline testing provides a definitive result - positive means the individual has the syndrome, negative means they do not 1
- If no family mutation has been identified yet, first seek to test an affected family member to identify the causative mutation 1, 2
Surveillance Recommendations Based on Syndrome Type
Familial Adenomatous Polyposis (FAP)
- For classic FAP, begin colorectal screening at age 10-12 years 1, 3
- Flexible sigmoidoscopy or colonoscopy should be performed:
- Every 12 months until age 24 years
- Every 2 years until age 34 years
- Every 3 years until age 44 years
- Then every 3-5 years thereafter 1
- Upper endoscopy and side-viewing duodenoscopy beginning at age 30-35 years and every 3-5 years 1
Attenuated FAP
- Begin colonoscopy in late teens, then every 2-3 years 1
- Upper endoscopy and side-viewing duodenoscopy beginning at age 30-35 years and every 3-5 years 1
MUTYH-Associated Polyposis (MAP)
- Begin colonoscopy at age 18-20 years, annually 1
- Upper endoscopy and duodenoscopy starting at age 35, frequency based on findings 1
Lynch Syndrome
- MLH1 or MSH2 mutation carriers: Begin colonoscopy at age 20-25 years, every 1-2 years 1
- MSH6 or PMS2 mutation carriers: Begin colonoscopy at age 25-30 years, every 1-2 years 1
- Upper endoscopy every 1-2 years from age 30-35 1
- For women: Consider endometrial biopsy every 1-2 years and regular vaginal ultrasound with serum CA125 testing 1
Important Considerations for Family Management
- Genetic testing allows for targeted surveillance of only those carrying the mutation, avoiding unnecessary procedures for non-carriers 1, 2
- Family members who test negative for the known family mutation do not require continued surveillance 1
- Between one-third and half of new FAP cases represent de novo mutations with no family history 3, 2
- The position of the APC mutation correlates with disease severity and may influence management decisions 3, 2
Surgical Considerations
- For FAP patients with advanced disease, surgical options include:
- Timing of surgery depends on polyp burden, age, and family history of early colorectal cancer 1
Follow-up After Surgery
- After colectomy, annual endoscopic examination of the retained rectum is required 1
- Lifelong surveillance for extracolonic manifestations is necessary 1, 3